Portfolio

ESCAPE-NEXT Trial Logo
Project Decription ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with
Alberta Hope COVID-19 Trial Logo
Project Decription One of the first projects on our DCTMS platform, the Alberta Hope COVID-19 Trial was a province-wide lead by researchers at the University of Calgary and the Univeristy of Edmonton to investi
AcT QuICR Logo
Project Decription One of the first projects on our DCTMS platform, the AcT trial is a Pragmatic Phase III randomized open-label registry-based trial with blinded end-point assessment. The trial seeks to test w